Minnesota trade group's discussion to focus on FDA's 510(k) process

02/16/2010 | Star Tribune (Minneapolis-St. Paul, Minn.)

The Minnesota Medical Device Alliance is scheduled today to meet to discuss the possible changes to the FDA's 510(k) clearance process that is being reviewed by the Institute of Medicine. The state's medical-device sector believes that a stricter regulatory process could restrict research and make it difficult for companies to bring innovative products to the market.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX